ArticleCureus2025
Advanced Insights Into Intravascular Bloodstream Infections: A Cross-Sectional Study of the Molecular Characterization of World Health Organization Priority Pathogens and Antimicrobial Resistance Patterns at a Tertiary Care Hospital.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Bloodstream infections (BSIs), particularly intravascular types such as catheter-related bloodstream infections (CRBSIs) and infective endocarditis (IE), represent a significant public health challenge due to their high morbidity and potential to rapidly progress to sepsis. The emergence of multidrug-resistant (MDR) pathogens necessitates molecular surveillance to inform effective antimicrobial strategies, especially in regions like India, where resistance data is limited. Methods A cross-sectional study was conducted over seven months, enrolling 101 patients from cardiology, nephrology, and ICUs at a tertiary care hospital in Chennai. Patients with confirmed intravascular BSIs were identified using clinical criteria and modified Duke's definitions. Blood cultures and catheter tip analyses were performed using standard microbiological techniques. Phenotypic resistance mechanisms were assessed via extended-spectrum beta-lactamase (ESBL), methicillin resistance, and CARBA NP testing. Molecular characterization included polymerase chain reaction (PCR) detection of resistance genes (blaKPC, blaNDM, blaCTX-M, blaTEM, OXA-23, OXA-48, mecA). Data were analyzed using IBM SPSS Statistics Version 31.0 (IBM Corp., Armonk, NY). Means and proportions were reported with 95% confidence intervals (CIs). Results The cohort included patients aged 13-68 years, with a male predominance (70 patients, 70%). CRBSIs accounted for 86 cases (85%). All patients underwent internal jugular vein (IJV) catheterization, primarily for hemodialysis in chronic kidney disease (CKD) (68 patients, 68%). Blood culture positivity was observed in 49 patients (48.5%), with Klebsiella pneumoniae (14 patients, 13.9%), Pseudomonas spp. (10 patients, 9.9%), and Staphylococcus aureus (8 patients, 7.9%) as dominant isolates. ESBL production was highest in Escherichia coli (four out of five isolates, 80%) and Klebsiella (10 out of 14 isolates, 71.4%). Carbapenemase genes blaNDM and blaKPC were detected in five out of 14 Klebsiella isolates (35.7%), while OXA-23 was found in five out of six Acinetobacter isolates (83.3%). A significant correlation was found between catheter duration and culture positivity using a scatter plot demonstration. Targeted antimicrobial therapy was successful in 71 patients (70%), although complications such as persistent bacteremia and septic shock were noted. Conclusions This study underscores the high prevalence of CRBSIs and the concerning presence of molecular resistance markers in key pathogens. The predominance of carbapenemase genes such as blaNDM, blaKPC, and OXA variants highlights the urgent need for molecular diagnostics and robust antibiotic stewardship in India. Continued surveillance of intravascular BSIs and resistance profiles is essential to improve clinical outcomes and combat antimicrobial resistance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.